Thyroid disease can sometimes cause repeated bouts of an itchy skin rash known as hives. In fact, up to 30% of people with chronic hives (also known as chronic urticaria) have an underlying autoimmune ...

Patients with CSU have an elevated risk of anxiety and depression, necessitating comprehensive management strategies. Research is focused on identifying biomarkers and clinical characteristics to ...

A prominent feature of CSU is its association with angioedema, observed in approximately 40% to 50% of patients with CSU; around 10% of patients primarily experience angioedema as the main symptom.

Urticarial vasculitis is an autoimmune condition that causes itchy or painful hives. Some people may also develop inflammation in other organs, such as the kidneys or lungs. Vasculitis is a group of ...

Chronic urticaria (CU) is a dermatological condition characterized by recurrent wheals (hives), angioedema (deep tissue swelling), or both, persisting for over 6 weeks. 1 Unlike acute urticaria, which ...

Chronic spontaneous urticaria (CSU), often referred to as hives, is a puzzling and often debilitating condition that affects millions of people worldwide. Characterized by the sudden and persistent ...

Sponsored by Novartis Pharmaceuticals Corporation, and Emmeka and Dr. Gupta were compensated by Novartis. Emmeka is a 28-year-old Iowa-based social media manager and beauty content creator, who began ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

EAST HANOVER, N.J., Sept. 30, 2025 /PRNewswire/ -- Novartis announced today that Rhapsido ® (remibrutinib) received US Food and Drug Administration (FDA) approval as an oral treatment for adult ...

BEIJING, Dec. 17, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today ...

The "Chronic Inducible Urticaria Market - A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.